Emergent BioSolutions Receives Approval from Singapore Health Sciences Authority for Expanded Indication of ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) to Include Mpox
Go back to Emergent BioSolutions Receives Approval from Singapore Health Sciences Authority for Expanded Indication of ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) to Include Mpox| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 7.98 +0.13 (1.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.85 | 52 Week High | $44.38 | |||
| Open | $7.80 | 52 Week Low | $24.47 | |||
| Day High | $8.07 | P/E | 399.00 | |||
| Day Low | $7.80 | EPS | $0.02 | |||
| Volume | 430,054 | |||||
